Skip to main content

Table 1 The baseline characteristics, clinic and laboratory features of the healthy subjects and renal transplant patients

From: Soluble TWEAK independently predicts atherosclerosis in renal transplant patients

Parameters

Healthy subjects (n=25) Median (IQR)

Transplant patients (n=70) Median (IQR)

P value

Age (years)

34 (29–43)

38 (31–47)

0.17

Female

13

29

0.48

BMI (kg/m 2 )

27 (24–29)

24.8 (21.4-28.4)

0.02

SBP (mmHg)

115 (110–120)

122 (110–137)

<0.0001

DBP (mmHg)

75 (60–80)

80 (70–90)

0.001

Glucose (mg/dL)

92 (86–105)

92 (86–104)

0.04

Urea(mg/dL)

25 (19–34)

32 (24–39)

0.002

Creatinine (mg/dL)

0.7 (0.6-0.8)

1.1 (0.8-1.4)

<0.0001

Albumin (g/dL)

4.4 (4.3-4.5)

4.3 (4.1-4.5)

0.02

Uric acid (mg/dL)

3.7 (3.5-4.6)

5.5 (3.9-7.0)

<0.0001

AST(IU/L)

21 (17–22)

21 (17–26)

0.25

ALT(IU/L)

18 (15–20)

19 (15–25)

0.18

LDL Cholesterol (mg/dL)

125 (105–137)

118 (92–134)

0.38

HDL Cholesterol (mg/dL)

46 (38–50)

46 (38–53)

0.69

Triglyceride (mg/dL)

64 (88–147)

144 (101–181)

0.001

Calcium (mg/dL)

8.5 (8.5-9.4)

9.5 (9.1-9.9)

0.0001

Phosphorus (mg/dL)

3.0 (2.7-3.3)

3.0 (2.7-3.6)

0.68

eGFR (ml/min)

107 (91–144)

71 (53–90)

<0.0001

Spot urine

0.08 (0.01-0.2)

0.2 (0.05-0.34)

<0.0001

protein/creatinine

   

ratio (g/mg)

   

Hemoglobin (mg/dL)

13.5 (13.3-14.3)

14 (12.6-14.7)

0.70

Neutrophil (mm 3 )

3100 (2520–3515)

4260 (3287–5937)

<0.0001

Lymphocyte (mm 3 )

2190 (1690–2583)

2100 (1582–2710)

0.29

  1. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, ALT alanine aminotransferase, AST aspartate aminotransferase, LDL low-density lipoprotein, HDL high-density lipoprotein, eGFR estimated glomerular filtration rate.